SSY GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.78 HKD | +0.21% |
|
+0.63% | -3.24% |
| Apr. 23 | SSY Group Get Production, Registration Approval for Pneumonia Drug from Chinese Regulator | MT |
| Apr. 16 | SSY Group Logs Nearly 15% Boost in Q1 Profit | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 19,134 | 13,392 | 12,047 | 12,812 | 14,667 | 14,162 | - | - |
| Enterprise Value (EV) 1 | 19,951 | 14,374 | 13,490 | 14,352 | 14,667 | 14,162 | 14,162 | 14,162 |
| P/E ratio | 16.9 x | 21.9 x | 15.5 x | 11.5 x | 11.2 x | 9.04 x | 7.65 x | 6.81 x |
| Yield | 1.74% | 2.27% | 2.99% | 3.25% | 3.44% | 3.56% | 3.77% | 1.89% |
| Capitalization / Revenue | 4.13 x | 3.14 x | 2.25 x | 1.99 x | 2.27 x | 1.87 x | 1.6 x | 1.44 x |
| EV / Revenue | 4.13 x | 3.14 x | 2.25 x | 1.99 x | 2.27 x | 1.87 x | 1.6 x | 1.44 x |
| EV / EBITDA | 11.5 x | 12.4 x | 8.74 x | 7.14 x | 7.17 x | 6.71 x | 5.9 x | 5.84 x |
| EV / FCF | -166 x | 73.2 x | 39.2 x | 40.6 x | - | 15.8 x | 8.47 x | 7.99 x |
| FCF Yield | -0.6% | 1.37% | 2.55% | 2.46% | - | 6.35% | 11.8% | 12.5% |
| Price to Book | 3.83 x | 2.37 x | 1.95 x | 2.07 x | 2.12 x | 1.77 x | 1.53 x | 1.32 x |
| Nbr of stocks (in thousands) | 3,032,325 | 3,043,727 | 2,996,689 | 2,972,683 | 2,969,043 | 2,969,043 | - | - |
| Reference price 2 | 6.310 | 4.400 | 4.020 | 4.310 | 4.940 | 4.770 | 4.770 | 4.770 |
| Announcement Date | 3/30/20 | 3/30/21 | 3/29/22 | 3/28/23 | 3/27/24 | - | - | - |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,636 | 4,261 | 5,357 | 6,434 | 6,463 | 7,583 | 8,825 | 9,858 |
| EBITDA 1 | 1,669 | 1,077 | 1,378 | 1,794 | 2,044 | 2,110 | 2,400 | 2,423 |
| EBIT 1 | 1,392 | 758.9 | 988.1 | 1,424 | 1,639 | 1,877 | 2,149 | 2,229 |
| Operating Margin | 30.02% | 17.81% | 18.45% | 22.13% | 25.36% | 24.75% | 24.35% | 22.61% |
| Earnings before Tax (EBT) 1 | 1,361 | 725.2 | 948.4 | 1,399 | 1,584 | 1,879 | 2,207 | 2,490 |
| Net income 1 | 1,136 | 612 | 785.5 | 1,123 | 1,319 | 1,570 | 1,844 | 2,076 |
| Net margin | 24.51% | 14.36% | 14.66% | 17.45% | 20.4% | 20.7% | 20.89% | 21.06% |
| EPS 2 | 0.3725 | 0.2012 | 0.2591 | 0.3761 | 0.4426 | 0.5275 | 0.6233 | 0.7000 |
| Free Cash Flow 1 | -115.5 | 183 | 307.3 | 315.6 | - | 899 | 1,673 | 1,772 |
| FCF margin | -2.49% | 4.3% | 5.74% | 4.9% | - | 11.86% | 18.96% | 17.98% |
| FCF Conversion (EBITDA) | - | 16.99% | 22.3% | 17.59% | - | 42.6% | 69.72% | 73.13% |
| FCF Conversion (Net income) | - | 29.91% | 39.12% | 28.1% | - | 57.27% | 90.73% | 85.36% |
| Dividend per Share 2 | 0.1100 | 0.1000 | 0.1200 | 0.1400 | 0.1700 | 0.1700 | 0.1800 | 0.0900 |
| Announcement Date | 3/30/20 | 3/30/21 | 3/29/22 | 3/28/23 | 3/27/24 | - | - | - |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S2 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income | - |
| Net margin | - |
| EPS 1 | 0.1855 |
| Dividend per Share | - |
| Announcement Date | 3/28/23 |
1HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | 817 | 981 | 1,443 | 1,540 | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.4895 x | 0.9108 x | 1.047 x | 0.8583 x | - | - | - | - |
| Free Cash Flow 1 | -115 | 183 | 307 | 316 | - | 899 | 1,673 | 1,772 |
| ROE (net income / shareholders' equity) | 24.6% | 11.5% | 13.2% | 18.1% | 20.1% | 20.4% | 21% | 20.2% |
| ROA (Net income/ Total Assets) | 15.6% | 7.21% | 7.87% | 10.4% | 11.5% | 12.8% | 13.3% | 13.4% |
| Assets 1 | 7,302 | 8,489 | 9,981 | 10,837 | 11,466 | 12,225 | 13,823 | 15,539 |
| Book Value Per Share 2 | 1.650 | 1.860 | 2.060 | 2.080 | 2.330 | 2.690 | 3.120 | 3.620 |
| Cash Flow per Share 2 | 0.2100 | 0.1700 | 0.2300 | 0.2500 | - | 0.5000 | 0.6100 | - |
| Capex 1 | 836 | 322 | 388 | 418 | - | 592 | 541 | 398 |
| Capex / Sales | 18.03% | 7.55% | 7.25% | 6.5% | - | 7.8% | 6.13% | 4.04% |
| Announcement Date | 3/30/20 | 3/30/21 | 3/29/22 | 3/28/23 | 3/27/24 | - | - | - |
1HKD in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.77
HKD
Average target price
6.227
HKD
Spread / Average Target
+30.54%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.24% | 1.81B | |
| +26.47% | 664B | |
| +29.72% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +14.26% | 234B | |
| +4.96% | 199B | |
| -10.06% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- 2005 Stock
- Financials SSY Group Limited
